Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Chia-jen Liu,Irene M. Ghobrial,Mark Bustoros,Kaitlen Reyes,Kalvis Hornburg,Ashraf Z. Badros,James J. Vredenburgh,Adam Boruchov,Jeffrey V Matous,Aaron Caola,Bradley Rivotto,Alexandra Savell,Patrick Henrick,Claudia E. Paba-Prada,Robert L. Schlossman,Jacob Laubach,Jacalyn Rosenblatt,Andrew J Yee,Omar Nadeem,Rodrigo O. Maegawa Blood(2018)
AI 理解论文
溯源树
样例